Amylyx Pharmaceuticals announced the election of Nobel Laureate and former Biogen CEO Walter Gilbert, PhD, to the company's board of directors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.76 USD | +3.23% | +5.39% | -88.04% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-88.04% | 12Cr | |
+0.99% | 9.17TCr | |
0.00% | 3.94TCr | |
-8.52% | 3.45TCr | |
+65.46% | 2.67TCr | |
-17.37% | 1.51TCr | |
-5.99% | 1.33TCr | |
-10.69% | 1.17TCr | |
-47.78% | 1.05TCr | |
+8.09% | 941.14Cr |
- Stock Market
- Equities
- AMLX Stock
- News Amylyx Pharmaceuticals, Inc.
- Amylyx Pharmaceuticals Appoints Walter Gilbert to Board of Directors